Tobacco Control and Tobacco Caused Cancers Pilot Projects
This year, the Hollings Cancer Center was able to fund projects for Tobacco Control and Tobacco Caused Cancer Research through the cigarette tax money received from the state of South Carolina. This funding opportunity was made available to researchers throughout the state. The same review process was used for these applications as for the Translational Research Pilot Projects. These projects were funded at or around $75,000 each. Tobacco Control & Tobacco-Caused Cancer Pilot Projects | Name | Project Title | John Baatz & Demetri Spyropoulos, PhD, Department of Pediatrics and Pathology & Laboratory Medicine Co-investigators/collaborators: George Simon, Patrick Flume | Viable Tissue Biorepository from Lung Lobectomy | Matthew Carpenter, PhD, Department of Psychiatry & Behavioral Health Co-investigators/collaborators: Michael Cummings, Karen Cropsey, Katy Wynne, (DHEC), Gerard Silvestri, Kevin Gray, Bianca F. Jardin, Amy E. Wahlquist | A Pilot Translational Study of Sampling NRT for Cessation Induction: Is Motivation Necessary? | Terry Day, MD, Department of Otolaryngology Co-investigators/collaborators: Steven Rosenzweig, Besim Ogretmen, Anthony Alberg, Matthew Carpenter, Marvella Ford, Marion B. Gillespie, Katherine D. Sterba, Elizabeth Garrett-Mayer | A Transdisciplinary Prospective Cohort Study to Understand the Root Causes of the Racial Disparity in HNSCC Survival | Campbell McInnes, PhD, Department of Pharmaceutical and Biomedical Sciences (USC) Co-investigators/collaborators: Michael D. Wyatt, Charles D Smith, John Lazo, U.niversity of Virginia; Guillermo Montoya, Crystallography, Spanish National Cancer Institute | Selective Plk1 Anti-Tumor Therapeutics through Polo Box Domain Inhibition | Besim Ogretmen, PhD, Department of Biochemistry & Molecular Biology Co-investigators/collaborators: George R. Simon, Yusuf A. Hannun, Elizabeth Garrett-Mayer, Angen Liu | Development of Targeted Therapeutics against SCLC | Dennis Watson, PhD, Department of Pathology & Laboratory Medicine Co-investigators/collaborators: Patricia Watson, Chadrick E. Denlinger, Angen Liu, Betsy Hill | Contribution of Alternative Splicing to Lung Cancer Progression |
University of Colorado/MUSC NCI Lung SPORE The HCC, through its collaboration with the University of Colorado/MUSC NCI Lung SPORE, awarded Eduardo Maldonado, PhD a career development award. Dr. Maldonado’s project was funded for $50,000. Lung SPORE – Career Development Award | Name | Project Title | Eduardo Maldonado, DVM, PhD, Department of Pharmaceutical & Biomedical Sciences John J. Lemasters | Drug Discovery Against Warburg Metabolism in Lung Cancer Cells |
|
86 Jonathan Lucas Street 
